Adalimumab/infliximabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1893卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09801-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[1] InfliximabDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1847 (1) : 244 - 244
[2] InfliximabDevelopment of acquired resistance: case report
Reactions Weekly, 2023, 1939 (1) : 250 - 250
[3] InfliximabDevelopment of drug specific antibodies: case report
Reactions Weekly, 2023, 1962 (1) : 224 - 224
[4] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
Reactions Weekly, 2018, 1701 (1) : 15 - 15
[5] InfliximabDevelopment of drug specific antibodies: case report
Reactions Weekly, 2019, 1742 (1) : 126 - 126
[6] InfliximabDevelopment of drug-specific antibodies: case report
Reactions Weekly, 2023, 1968 (1) : 173 - 173
[7] Adalimumab/etanercept/infliximabDevelopment of autoantibodies: 37 case reports
Reactions Weekly, 2015, 1537 (1) : 16 - 16
[8] InfliximabDevelopment of antibodies: case report
Reactions Weekly, 2016, 1587 (1) : 159 - 159
[9] InfliximabDevelopment of antibodies to infliximab: case report
Reactions Weekly, 2019, 1739 (1) : 152 - 152
[10] InfliximabDevelopment of antibodies to infliximab: case report
Reactions Weekly, 2018, 1687 (1) : 116 - 116

← 1 2 3 4 5 →